David A. Khan 被任命为 AAAAI 新任执行副总裁
David A. Khan, MD, FAAAAI, Named New AAAAI Executive Vice President
美国过敏、哮喘与免疫学会（AAAAI）宣布 David A. Khan 将于 2027 年 1 月出任执行副总裁。Khan 曾于 2022-2023 年担任 AAAAI 主席，现任 UT Southwestern 项目主任及医学与儿科教授。他将与退休的执行副总裁 Thomas Fleisher 短暂交接，直至 2027 年 AAAAI 年会结束。
Dr. Khan will assume the Executive Vice President role in January 2027.
, /PRNewswire/ -- The American Academy of Allergy, Asthma & Immunology (AAAAI) is pleased to announce David A. Khan, MD, FAAAAI, as our next Executive Vice President. Dr. Khan will assume the role in January 2027.
"My year as President went by far too quickly, and I wished I could have extended the experience," said Dr. Khan. "The opportunity to serve as Executive Vice President offers a wonderful continuation of that journey. One of the things I value most about the AAAAI is working with an exceptional group of people, including the Board of Directors and dedicated staff, who share a common purpose. That kind of collective passion is truly special. I look forward to continuing to work with those who are committed to advancing the AAAAI's mission and supporting our specialty."
Dr. Khan previously served as President of the AAAAI from 2022-2023 and currently serves as a program director and Professor of Medicine and Pediatrics at UT Southwestern and as an Associate Editor of The Journal of Allergy and Clinical Immunology: In Practice. During his long history of leadership and involvement with the AAAAI, Dr. Khan served as Chair of the Program Directors Section, Chair of the Food Allergy, Anaphylaxis, Dermatology and Drug Allergy Section and Chair of the In-Training Examination Committee. He was also a member of the AAAAI Joint Task Force on Practice Parameters for 16 years and served as Chair of the AAAAI Foundation Council (2023-2024). Dr. Khan will step into his new role of Executive Vice President in January, briefly overlapping with the retiring Executive Vice President, Thomas Fleisher, MD, FAAAAI, until the conclusion of the 2027 AAAAI Annual Meeting.
Visit aaaai.org to learn more about the AAAAI Board of Directors.
The American Academy of Allergy, Asthma & Immunology (AAAAI) is the leading membership organization of more than 7,100 allergists, asthma specialists, clinical immunologists and other professionals with a special interest in the research and treatment of allergic and immunologic diseases. Established in 1943, the AAAAI is the go-to resource for patients living with allergies, asthma and immune deficiency disorders.
SOURCE American Academy of Allergy, Asthma & Immunology (AAAAI)
来源：PR Newswire Health · prnewswire.com